BioCentury
ARTICLE | Company News

Dishman Pharmaceuticals & Chemical, Redx Pharma deal

September 24, 2012 7:00 AM UTC

Redx granted Dishman rights to IP covering its process technology to develop statins. Redx declined to provide details, while Dishman could not be reached. ...